{"count": 12, "results": [{"_id": "37513826", "pmid": 37513826, "pmcid": "PMC10385015", "title": "The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action", "journal": "Pharmaceuticals (Basel)", "authors": ["Vuu YM", "Kadar Shahib A", "Rastegar M"], "date": "2023-06-22T00:00:00Z", "doi": "10.3390/ph16070914", "meta_date_publication": "2023 Jun 22", "meta_volume": "16", "meta_issue": "7", "meta_pages": "", "score": 50271.008, "text_hl": "Recent studies have suggested that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ could be a promising therapeutic option for different @DISEASE_Brain_Diseases @DISEASE_MESH:D001927 @@@brain complications@@@ and diseases ranging from @DISEASE_Brain_Neoplasms @DISEASE_MESH:D001932 @@@brain tumors@@@ (i.e., @DISEASE_Medulloblastoma @DISEASE_MESH:D008527 @@@medulloblastoma@@@ and @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@) to @DISEASE_Neurologic_Manifestations @DISEASE_MESH:D009461 @@@neurological disorders@@@ (i.e., @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, and @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@Huntington's disease@@@). ", "citations": {"NLM": "Vuu YM, Kadar Shahib A, Rastegar M. The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action Pharmaceuticals (Basel). 2023 Jun 22;16(7):. PMID: 37513826", "BibTeX": "@article{37513826, title={The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action}, author={Vuu YM and Kadar Shahib A and Rastegar M}, journal={Pharmaceuticals (Basel)}, volume={16}, number={7}}"}}, {"_id": "32172201", "pmid": 32172201, "title": "Inverse screening of Simvastatin kinase targets from glioblastoma druggable kinome.", "journal": "Comput Biol Chem", "authors": ["Li Y", "Wei X", "Wang Q", "Li W", "Yang T"], "date": "2020-06-01T00:00:00Z", "doi": "10.1016/j.compbiolchem.2020.107243", "meta_date_publication": "2020 Jun", "meta_volume": "86", "meta_issue": "", "meta_pages": "107243", "score": 50268.617, "text_hl": "It is revealed that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ can potentially interact with certain known targets or key regulators of @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@GBM@@@ such as @GENE_EGFR @GENE_1956 @@@ErbB@@@, @GENE_SRC @GENE_6714 @@@c-Src@@@ and FGFR signaling pathways, but exhibit low affinity to the well-established @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@GBM@@@ target of PI3K/@GENE_AKT1 @GENE_207 @@@Akt@@@/@GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway. ", "citations": {"NLM": "Li Y, Wei X, Wang Q, Li W, Yang T. Inverse screening of Simvastatin kinase targets from glioblastoma druggable kinome. Comput Biol Chem. 2020 Jun;86():107243. PMID: 32172201", "BibTeX": "@article{32172201, title={Inverse screening of Simvastatin kinase targets from glioblastoma druggable kinome.}, author={Li Y and Wei X and Wang Q and Li W and Yang T}, journal={Comput Biol Chem}, volume={86}, pages={107243}}"}}, {"_id": "31545550", "pmid": 31545550, "title": "Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.", "journal": "FEBS J", "authors": ["Shojaei S", "Koleini N", "Samiei E", "Aghaei M", "Cole LK", "Alizadeh J", "Islam MI", "Vosoughi AR", "Albokashy M", "Butterfield Y", "Marzban H", "Xu F", "Thliveris J", "Kardami E", "Hatch GM", "Eftekharpour E", "Akbari M", "Hombach-Klonisch S", "Klonisch T", "Ghavami S"], "date": "2020-03-01T00:00:00Z", "doi": "10.1111/febs.15069", "meta_date_publication": "2020 Mar", "meta_volume": "287", "meta_issue": "5", "meta_pages": "1005-1034", "score": 50264.875, "text_hl": "In this study, we investigated the potentiation of @CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@TMZ@@@-induced apoptosis by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simva@@@) in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@GBM@@@ cell lines and @SPECIES_9606 @@@patient@@@ @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@GBM@@@ cells, using cell monolayers and three-dimensional cell culture systems. ", "citations": {"NLM": "Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y, Marzban H, Xu F, Thliveris J, Kardami E, Hatch GM, Eftekharpour E, Akbari M, Hombach-Klonisch S, Klonisch T, Ghavami S. Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. FEBS J. 2020 Mar;287(5):1005-1034. PMID: 31545550", "BibTeX": "@article{31545550, title={Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.}, author={Shojaei S and Koleini N and Samiei E and Aghaei M and Cole LK and Alizadeh J and Islam MI and Vosoughi AR and Albokashy M and Butterfield Y and Marzban H and Xu F and Thliveris J and Kardami E and Hatch GM and Eftekharpour E and Akbari M and Hombach-Klonisch S and Klonisch T and Ghavami S}, journal={FEBS J}, volume={287}, number={5}, pages={1005-1034}}"}}, {"_id": "35158983", "pmid": 35158983, "pmcid": "PMC8833738", "title": "Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines", "journal": "Cancers (Basel)", "authors": ["Wróbel K", "Wołowiec S", "Markowicz J", "Wałajtys-Rode E", "Uram Ł"], "date": "2022-01-29T00:00:00Z", "doi": "10.3390/cancers14030714", "meta_date_publication": "2022 Jan 29", "meta_volume": "14", "meta_issue": "3", "meta_pages": "", "score": 50264.32, "text_hl": "Despite this, it may be concluded that biotinylated and R-glycidylated PAMAM G3 @CHEMICAL_Dendrimers @CHEMICAL_MESH:D050091 @@@dendrimers@@@ substituted with both @CHEMICAL_Celecoxib @CHEMICAL_MESH:D000068579 @@@celecoxib@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ can be considered as a new perspective anticancer agent, effective in therapy of malignant, incurable @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastomas@@@.", "citations": {"NLM": "Wróbel K, Wołowiec S, Markowicz J, Wałajtys-Rode E, Uram Ł. Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines Cancers (Basel). 2022 Jan 29;14(3):. PMID: 35158983", "BibTeX": "@article{35158983, title={Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines}, author={Wróbel K and Wołowiec S and Markowicz J and Wałajtys-Rode E and Uram Ł}, journal={Cancers (Basel)}, volume={14}, number={3}}"}}, {"_id": "36907105", "pmid": 36907105, "pmcid": "PMC10024193", "title": "Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence", "journal": "EBioMedicine", "authors": ["Fuentes-Fayos AC", "G-García ME", "Pérez-Gómez JM", "Montero-Hidalgo AJ", "Martín-Colom J", "Doval-Rosa C", "Blanco-Acevedo C", "Torres E", "Toledano-Delgado Á", "Sánchez-Sánchez R", "Peralbo-Santaella E", "Ortega-Salas RM", "Jiménez-Vacas JM", "Tena-Sempere M", "López M", "Castaño JP", "Gahete MD", "Solivera J", "Luque RM"], "date": "2023-04-01T00:00:00Z", "doi": "10.1016/j.ebiom.2023.104484", "meta_date_publication": "2023 Apr", "meta_volume": "90", "meta_issue": "", "meta_pages": "104484", "score": 50261.62, "text_hl": "@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ exert additive antitumour effects in @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@ via senescence-state: clinical and translational evidence", "citations": {"NLM": "Fuentes-Fayos AC, G-García ME, Pérez-Gómez JM, Montero-Hidalgo AJ, Martín-Colom J, Doval-Rosa C, Blanco-Acevedo C, Torres E, Toledano-Delgado Á, Sánchez-Sánchez R, Peralbo-Santaella E, Ortega-Salas RM, Jiménez-Vacas JM, Tena-Sempere M, López M, Castaño JP, Gahete MD, Solivera J, Luque RM. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence EBioMedicine. 2023 Apr;90():104484. PMID: 36907105", "BibTeX": "@article{36907105, title={Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence}, author={Fuentes-Fayos AC and G-García ME and Pérez-Gómez JM and Montero-Hidalgo AJ and Martín-Colom J and Doval-Rosa C and Blanco-Acevedo C and Torres E and Toledano-Delgado Á and Sánchez-Sánchez R and Peralbo-Santaella E and Ortega-Salas RM and Jiménez-Vacas JM and Tena-Sempere M and López M and Castaño JP and Gahete MD and Solivera J and Luque RM}, journal={EBioMedicine}, volume={90}, pages={104484}}"}}, {"_id": "33105603", "pmid": 33105603, "pmcid": "PMC7690447", "title": "Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells", "journal": "Cells", "authors": ["Dastghaib S", "Shojaei S", "Mostafavi-Pour Z", "Sharma P", "Patterson JB", "Samali A", "Mokarram P", "Ghavami S"], "date": "2020-10-22T00:00:00Z", "doi": "10.3390/cells9112339", "meta_date_publication": "2020 Oct 22", "meta_volume": "9", "meta_issue": "11", "meta_pages": "", "score": 50261.277, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Induces Unfolded Protein Response and Enhances @CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@Temozolomide@@@-Induced Cell Death in @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@Glioblastoma@@@ Cells", "citations": {"NLM": "Dastghaib S, Shojaei S, Mostafavi-Pour Z, Sharma P, Patterson JB, Samali A, Mokarram P, Ghavami S. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells Cells. 2020 Oct 22;9(11):. PMID: 33105603", "BibTeX": "@article{33105603, title={Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells}, author={Dastghaib S and Shojaei S and Mostafavi-Pour Z and Sharma P and Patterson JB and Samali A and Mokarram P and Ghavami S}, journal={Cells}, volume={9}, number={11}}"}}, {"_id": "36829578", "pmid": 36829578, "pmcid": "PMC9953749", "title": "Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial-Dependent Apoptosis in GBM Cells, Which Is Regulated by Autophagy", "journal": "Biology (Basel)", "authors": ["Hajiahmadi S", "Lorzadeh S", "Iranpour R", "Karima S", "Rajabibazl M", "Shahsavari Z", "Ghavami S"], "date": "2023-02-14T00:00:00Z", "doi": "10.3390/biology12020302", "meta_date_publication": "2023 Feb 14", "meta_volume": "12", "meta_issue": "2", "meta_pages": "", "score": 50260.055, "text_hl": "@CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@Temozolomide@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_acetylshikonin @CHEMICAL_MESH:C073944 @@@Acetylshikonin@@@ Combination Induces Mitochondrial-Dependent Apoptosis in @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@GBM@@@ Cells, Which Is Regulated by Autophagy", "citations": {"NLM": "Hajiahmadi S, Lorzadeh S, Iranpour R, Karima S, Rajabibazl M, Shahsavari Z, Ghavami S. Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial-Dependent Apoptosis in GBM Cells, Which Is Regulated by Autophagy Biology (Basel). 2023 Feb 14;12(2):. PMID: 36829578", "BibTeX": "@article{36829578, title={Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial-Dependent Apoptosis in GBM Cells, Which Is Regulated by Autophagy}, author={Hajiahmadi S and Lorzadeh S and Iranpour R and Karima S and Rajabibazl M and Shahsavari Z and Ghavami S}, journal={Biology (Basel)}, volume={12}, number={2}}"}}, {"_id": "30159829", "pmid": 30159829, "title": "Preparation and Characterization of Simvastatin Nanocapsules: Encapsulation of Hydrophobic Drugs in Calcium Alginate.", "journal": "Methods Mol Biol", "authors": ["Ahmadi M", "Madrakian T", "Ghavami S"], "date": "2020-01-01T00:00:00Z", "doi": "10.1007/7651_2018_191", "meta_date_publication": "2020", "meta_volume": "2125", "meta_issue": "", "meta_pages": "47-56", "score": 50258.95, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ belongs to a group of @CHEMICAL_Mevalonic_Acid @CHEMICAL_MESH:D008798 @@@mevalonate@@@ cascade inhibitors (statins) which have recently been considered as a possible new approach in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ treatment especially @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@. ", "citations": {"NLM": "Ahmadi M, Madrakian T, Ghavami S. Preparation and Characterization of Simvastatin Nanocapsules: Encapsulation of Hydrophobic Drugs in Calcium Alginate. Methods Mol Biol. 2020;2125():47-56. PMID: 30159829", "BibTeX": "@article{30159829, title={Preparation and Characterization of Simvastatin Nanocapsules: Encapsulation of Hydrophobic Drugs in Calcium Alginate.}, author={Ahmadi M and Madrakian T and Ghavami S}, journal={Methods Mol Biol}, volume={2125}, pages={47-56}}"}}, {"_id": "35151819", "pmid": 35151819, "title": "Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.", "journal": "Int J Pharm", "authors": ["Bruinsmann FA", "de Cristo Soares Alves A", "de Fraga Dias A", "Lopes Silva LF", "Visioli F", "Raffin Pohlmann A", "Figueiró F", "Sonvico F", "Stanisçuaski Guterres S"], "date": "2022-03-25T00:00:00Z", "doi": "10.1016/j.ijpharm.2022.121563", "meta_date_publication": "2022 Mar 25", "meta_volume": "616", "meta_issue": "", "meta_pages": "121563", "score": 50258.21, "text_hl": "Despite @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SVT@@@) showing potential anticancer properties, its antitumoral effect against @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@ appears limited when the conventional oral administration route is selected. ", "citations": {"NLM": "Bruinsmann FA, de Cristo Soares Alves A, de Fraga Dias A, Lopes Silva LF, Visioli F, Raffin Pohlmann A, Figueiró F, Sonvico F, Stanisçuaski Guterres S. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo. Int J Pharm. 2022 Mar 25;616():121563. PMID: 35151819", "BibTeX": "@article{35151819, title={Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.}, author={Bruinsmann FA and de Cristo Soares Alves A and de Fraga Dias A and Lopes Silva LF and Visioli F and Raffin Pohlmann A and Figueiró F and Sonvico F and Stanisçuaski Guterres S}, journal={Int J Pharm}, volume={616}, pages={121563}}"}}, {"_id": "20044596", "pmid": 20044596, "title": "HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model.", "journal": "Anticancer Res", "authors": ["Bababeygy SR", "Polevaya NV", "Youssef S", "Sun A", "Xiong A", "Prugpichailers T", "Veeravagu A", "Hou LC", "Steinman L", "Tse V"], "date": "2009-12-01T00:00:00Z", "meta_date_publication": "2009 Dec", "meta_volume": "29", "meta_issue": "12", "meta_pages": "4901-8", "score": 50060.23, "text_hl": "MATERIALS AND METHODS: An orthotopic @SPECIES_10090 @@@mouse@@@ @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@ (@CELLLINE_CVCL:8806 @@@GL-26@@@) model was used to investigate the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Glioblastoma</m> @DISEASE_MESH:D005909 @@@glioblastoma@@@ vasculature in vivo. ", "citations": {"NLM": "Bababeygy SR, Polevaya NV, Youssef S, Sun A, Xiong A, Prugpichailers T, Veeravagu A, Hou LC, Steinman L, Tse V. HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res. 2009 Dec;29(12):4901-8. PMID: 20044596", "BibTeX": "@article{20044596, title={HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model.}, author={Bababeygy SR and Polevaya NV and Youssef S and Sun A and Xiong A and Prugpichailers T and Veeravagu A and Hou LC and Steinman L and Tse V}, journal={Anticancer Res}, volume={29}, number={12}, pages={4901-8}}"}}]}